Location History:
- Koto-ku, JP (2014 - 2016)
- Tokyo, JP (2014 - 2018)
Company Filing History:
9 out of 143 
3 out of 7 Years Active: 2014-2018
Title: Shintarou Katou: Innovator in Nucleic Acid Technology
Introduction
Shintarou Katou is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of nucleic acid technology, holding a total of nine patents. His work focuses on innovative methods for evaluating and analyzing nucleic acid molecules, which have important implications in various scientific and medical applications.
Latest Patents
One of his latest patents is a method for evaluating the redox activity of nucleic acid molecules. This invention provides a novel technique for assessing the redox activity of these molecules through an electrochemical detection process. The method involves detecting a redox reaction catalyzed by the nucleic acid molecule using a specialized device. The evaluation step allows for the assessment of the redox activity based on the detection results. Another significant patent is a device and method for analyzing targets using a nucleic acid sensor. This sensor includes a catalyst nucleic acid molecule and a binding nucleic acid molecule that work together to detect specific targets. The innovative design of the nucleic acid element allows for the catalytic function to be activated in the presence of a target, showcasing the potential for advanced detection capabilities.
Career Highlights
Shintarou Katou has worked with notable organizations such as NEC Solution Innovators, Ltd. and the Kanagawa Prefectural Hospital Organization. His experience in these institutions has allowed him to develop and refine his innovative ideas in nucleic acid technology.
Collaborations
Throughout his career, Shintarou has collaborated with esteemed colleagues, including Jou Akitomi and Iwao Waga. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Shintarou Katou is a distinguished inventor whose work in nucleic acid technology has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to scientific progress and the potential impact of his inventions on future research and applications.